These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 32024694)

  • 1. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
    Hartman Z; Geldenhuys WJ; Agazie YM
    J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling.
    Agazie YM; Hayman MJ
    Mol Cell Biol; 2003 Nov; 23(21):7875-86. PubMed ID: 14560030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP2-EGFR States in Dephosphorylation Can Inform Selective SHP2 Inhibitors, Dampening RasGAP Action.
    Liu Y; Jang H; Nussinov R
    J Phys Chem B; 2024 May; 128(21):5175-5187. PubMed ID: 38747619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism for SHP2 in promoting HER2-induced signaling and transformation.
    Zhou X; Agazie YM
    J Biol Chem; 2009 May; 284(18):12226-34. PubMed ID: 19261604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling.
    Keilhack H; Tenev T; Nyakatura E; Godovac-Zimmermann J; Nielsen L; Seedorf K; Böhmer FD
    J Biol Chem; 1998 Sep; 273(38):24839-46. PubMed ID: 9733788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation.
    Montagner A; Yart A; Dance M; Perret B; Salles JP; Raynal P
    J Biol Chem; 2005 Feb; 280(7):5350-60. PubMed ID: 15574420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling.
    Vemulapalli V; Chylek LA; Erickson A; Pfeiffer A; Gabriel KH; LaRochelle J; Subramanian K; Cao R; Stegmaier K; Mohseni M; LaMarche MJ; Acker MG; Sorger PK; Gygi SP; Blacklow SC
    Elife; 2021 Mar; 10():. PubMed ID: 33755016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR-activated Src family kinases maintain GAB1-SHP2 complexes distal from EGFR.
    Furcht CM; Buonato JM; Lazzara MJ
    Sci Signal; 2015 May; 8(376):ra46. PubMed ID: 25969544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
    Fan YX; Wong L; Deb TB; Johnson GR
    J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling.
    Wang Q; Pan W; Wang S; Pan C; Ning H; Huang S; Chiu SH; Chen JL
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells.
    Bhattacharyya S; Feferman L; Han X; Ouyang Y; Zhang F; Linhardt RJ; Tobacman JK
    J Biol Chem; 2018 Jul; 293(28):11076-11087. PubMed ID: 29794138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2.
    Sturla LM; Amorino G; Alexander MS; Mikkelsen RB; Valerie K; Schmidt-Ullrichr RK
    J Biol Chem; 2005 Apr; 280(15):14597-604. PubMed ID: 15708852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an efficient "substrate-trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates.
    Agazie YM; Hayman MJ
    J Biol Chem; 2003 Apr; 278(16):13952-8. PubMed ID: 12582165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.
    Ren Y; Meng S; Mei L; Zhao ZJ; Jove R; Wu J
    J Biol Chem; 2004 Feb; 279(9):8497-505. PubMed ID: 14665621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
    Li X; Huang Y; Jiang J; Frank SJ
    Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant.
    Merritt R; Hayman MJ; Agazie YM
    Biochim Biophys Acta; 2006 Jan; 1763(1):45-56. PubMed ID: 16413071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.